A Phase I,Multicenter, Dose Escalation Study of CAT-8015 in Patients With Chronic Leukemia

This study has suspended participant recruitment.
(On hold due to lack of CTM supply)
Sponsor:
Collaborator:
Cambridge Antibody Technology
Information provided by (Responsible Party):
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT00587457
First received: December 21, 2007
Last updated: January 3, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: January 2012
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)